LicianPro

LIFECORE BIOMEDICAL, INC. DE ·

LFCR 8-K 2026-09-28

LIFECORE BIOMEDICAL, INC. DE (LFCR) 8-K dated 2026-09-28 — accession 0001140361-26-037767.

LIFECORE BIOMEDICAL, INC. DE (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.

LIFECORE BIOMEDICAL, INC. DE filed a 8-K on 2026-09-28. Accession 0001140361-26-037767.

This 8-K covers: Material agreement (Item 1.01), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported LFCR revenue for 2026-09-30 was $25.3M. Net income was -$40.1M. Revenue was down 25.9% from 2026-06-30 to 2026-09-30. LFCR currently screens at market cap $207.1M.

Not investment advice. The LFCR SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr